Age | 61 [54/69] |
Gender (female/male) | 14 (70 %)/6 (30 %) |
BMI (kg/m2) | 23 [22/26] |
Diagnosis leading to ICU stay | |
ARDS (ECMO, ECLA) | 6 (30 %) |
ARDS (without ECMO, ECLA) | 8 (40 %) |
Mediastinitis | 1 (5 %) |
Peritonitis | 3 (15 %) |
Intracranial hemorrhage | 1 (5 %) |
Polytrauma | 1 (5 %) |
At least one event of SIRS or sepsis during CGM | 20 (100 %) |
Sequential organ failure assessment (SOFA) Score at inclusion | 8 [4/10] |
Acute physiology and chronic health evaluation (APACHE) 2 Score at admission | 24 [19/28] |
History of diabetes mellitus | 5 (25 %) |
Administration of intravenous insulin therapy during CGM | 14 (70 %) |
Administration of vasopressors during CGM | 7 (35 %) |
Mean dose of epinephrine during sensor running time (µg/kg/min) (in seven patients receiving vasopressors) | 0.08 [0.03/0.14] |
Mortality during ICU stay | 4 (20 %) |